Skip to content. | Skip to navigation

Article l From Bench to Market

Article l From Bench to Market

Medium: The CEO Magazine

In its April edition The CEO Magazine, a business magazine for CEOs and high-level executive professionals, reports about European vaccine company Valneva.

Valneva and Vetter have forged a strong partnership over the last decade. 

CEO Thomas Lingelbach offers his insight about the company's efforts focussing on the commercialisation of innovative vaccines to better the lives of people all over the world.

To the Article

Back to newsroom